|
Real-time Estimate
Cboe BZX
01:20:55 2026-10-12 pm EDT
|
5-day change | 1st Jan Change | ||
| 28.42 USD | +0.48% |
|
+3.72% | +14.18% |
| 09:25am | Eli Lilly Likely to Raise Revenue Outlook Amid Strong Diabetes, Weight-Loss Drug Sales, RBC Says | MT |
| Oct. 09 | DBS Bank Adjusts Price Target on Pfizer to $35 From $30 | MT |
| Market Cap | 161B 144B 134B 122B 230B 15,600B 231B 1,612B 632B 7,953B 605B 592B 25,522B | P/E 2026 * |
17.9x | P/E 2027 * | 13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 209B 187B 174B 158B 298B 20,246B 300B 2,092B 820B 10,322B 786B 768B 33,124B | EV / Sales 2026 * |
3.36x | EV / Sales 2027 * | 3.38x |
| Free-Float |
59.05% | Yield 2026 * |
6.08% | Yield 2027 * | 6.14% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PFE | Delayed | |
CBOE
| PFE | Real-time | |
|
Tradegate
| PFE | Real-time | |
|
Xetra
| PFE | Delayed | |
|
Boerse Muenchen
| PFE | Real-time | |
|
London S.E.
| PFZ | Delayed | |
|
CBOE
| PFEs | Real-time | |
|
Mexican S.E.
| PFE * | End-of-day quote | |
|
Deutsche Boerse AG
| PFE | Delayed | |
|
Borsa Italiana
| 1PFE | End-of-day quote | |
|
Börse Stuttgart
| PFE | Delayed | |
|
Wiener Boerse
| PFE | End-of-day quote | |
|
Kazakhstan S.E.
| PFE_KZ | End-of-day quote | |
|
Bolsa De Valores De Colombia
| PFECO | End-of-day quote | |
|
Bulgaria S.E.
| PFE | End-of-day quote | |
|
Lima
| PFEUS | End-of-day quote | |
|
Santiago S.E.
| PFE | End-of-day quote | |
|
Santiago S.E.
| PFECL | End-of-day quote | |
|
CBOE
| PFZ | Real-time | |
|
Swiss Exchange
| PFE | Delayed | |
|
Swiss Exchange
| PFE | Delayed |
Last Transcript: Pfizer Inc.
| 1 day | +0.48% | ||
| 1 week | +3.48% | ||
| Current month | -0.54% | ||
| 1 month | +2.33% | ||
| 3 months | +15.87% | ||
| 6 months | +3.75% | ||
| Current year | +13.92% |
| 1 week | 27.2 |  | 28.5 |
| 1 month | 27.12 | | 28.94 |
| Current year | 23.62 | | 29.21 |
| 1 year | 23.62 | | 29.21 |
| 3 years | 20.92 | | 33.92 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Free | Chief Executive Officer | 21 | 0.0000% | ||
| 9/25/26 | Free | Director | 1,352 | 0.0000% | ||
| 9/25/26 | Free | Director | 1,570 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | +3.48% | +14.70% | -13.84% | 161B | |
| -0.39% | +2.70% | +43.28% | +92.30% | 1,051B | |
| +0.62% | +3.96% | +37.74% | +68.20% | 630B | |
| +1.45% | +5.42% | +21.65% | +88.91% | 489B | |
| -0.27% | +4.04% | +69.40% | +40.15% | 359B | |
| +0.61% | +3.18% | +24.10% | +42.46% | 344B | |
| +0.72% | +2.99% | +14.79% | +34.71% | 272B | |
| +0.23% | +2.23% | -5.49% | +8.15% | 246B | |
| +0.18% | +2.96% | +41.90% | +45.56% | 224B | |
| -0.67% | +3.77% | +26.96% | +95.52% | 187B | |
| Average | +0.25% | +2.75% | +28.90% | +50.21% | 396.49B | |
| Weighted average by Cap. | +0.23% | +2.88% | +33.44% | +63.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.23B 55.58B 51.7B 47.03B 88.79B 6,023B 89.18B 622B 244B 3,071B 234B 229B 9,854B | 59.93B 53.53B 49.79B 45.29B 85.51B 5,800B 85.88B 599B 235B 2,957B 225B 220B 9,490B |
| Net income | 8.89B 7.94B 7.38B 6.72B 12.68B 860B 12.74B 88.88B 34.82B 439B 33.38B 32.65B 1,407B | 11.05B 9.87B 9.18B 8.35B 15.77B 1,069B 15.83B 110B 43.29B 545B 41.49B 40.59B 1,750B |
| Net Debt | 48.01B 42.88B 39.89B 36.28B 68.5B 4,646B 68.8B 480B 188B 2,369B 180B 176B 7,602B | 41.47B 37.04B 34.46B 31.34B 59.18B 4,014B 59.43B 415B 162B 2,046B 156B 152B 6,567B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-12 | $28.42 | +0.48% | 7,721,981 |
| 26-10-09 | $28.28 | +1.65% | 23,204,131 |
| 26-10-08 | $27.82 | -0.64% | 44,433,417 |
| 26-10-07 | $28.00 | +1.82% | 31,230,398 |
| 26-10-06 | $27.50 | +0.33% | 24,066,071 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
